Protective porcine influenza virus-specific monoclonal antibodies recognize similar haemagglutinin epitopes as humans.
Protective porcine influenza virus-specific monoclonal antibodies recognize similar haemagglutinin epitopes as humans.
复制标题
DOI:
10.1371/journal.ppat.1009330
复制
发表时间:
2021-03
期刊:
影响因子:
6.7
通讯作者:
Tchilian E
中科院分区:
文献类型:
--
作者:
Holzer B;Rijal P;McNee A;Paudyal B;Martini V;Clark B;Manjegowda T;Salguero FJ;Bessell E;Schwartz JC;Moffat K;Pedrera M;Graham SP;Noble A;Bonnet-Di Placido M;La Ragione RM;Mwangi W;Beverley P;McCauley JW;Daniels RS;Hammond JA;Townsend AR;Tchilian E
Pigs are natural hosts for the same subtypes of influenza A viruses as humans and integrally involved in virus evolution with frequent interspecies transmissions in both directions. The emergence of the 2009 pandemic H1N1 virus illustrates the importance of pigs in evolution of zoonotic strains. Here we generated pig influenza-specific monoclonal antibodies (mAbs) from H1N1pdm09 infected pigs. The mAbs recognized the same two major immunodominant haemagglutinin (HA) epitopes targeted by humans, one of which is not recognized by post-infection ferret antisera that are commonly used to monitor virus evolution. Neutralizing activity of the pig mAbs was comparable to that of potent human anti-HA mAbs. Further, prophylactic administration of a selected porcine mAb to pigs abolished lung viral load and greatly reduced lung pathology but did not eliminate nasal shedding of virus after H1N1pdm09 challenge. Hence mAbs from pigs, which target HA can significantly reduce disease severity. These results, together with the comparable sizes of pigs and humans, indicate that the pig is a valuable model for understanding how best to apply mAbs as therapy in humans and for monitoring antigenic drift of influenza viruses in humans, thereby providing information highly relevant to making influenza vaccine recommendations. Antibodies (Ab) are increasingly used to treat human infectious diseases. Pigs are large animals, natural hosts for influenza viruses and very similar to humans. We generated monoclonal Abs from influenza infected pigs and show that they recognize the same sites of the virus as humans. One of these sites was not recognized by ferret anti-sera, which are commonly used to predict the evolution of the virus and inform vaccine design. We also show that prophylactic administration of one of these mAb to pigs abolished lung viral load and prevented lung damage following infection with influenza. We conclude that the pig is a useful model to test how best to use Abs for therapy and to inform vaccine recommendations for humans.
登录
查看更多内容
影响因子:
--
作者:
Haakenson, Jeremy K;Deiss, Thaddeus C;Smider, Vaughn V
通讯作者:
Smider, Vaughn V
影响因子:
4.4
作者:
Holzer, Barbara;Morgan, Sophie B.;Tchilian, Elma
通讯作者:
Tchilian, Elma
影响因子:
64.5
作者:
CATON, AJ;BROWNLEE, GG;GERHARD, W
通讯作者:
GERHARD, W
影响因子:
4.7
作者:
Dong, Haisi;Su, Ang;Ouyan, Hongsheng
通讯作者:
Ouyan, Hongsheng
影响因子:
64.5
作者:
Bangaru, Sandhya;Lang, Shanshan;Crowe, James E., Jr.
通讯作者:
Crowe, James E., Jr.